Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is myocardial adrenergic responsiveness depressed in human septic shock?
Cariou A, Pinsky MR, Monchi M, Laurent I, Vinsonneau C, Chiche JD, Charpentier J, Dhainaut JF. Cariou A, et al. Among authors: charpentier j. Intensive Care Med. 2008 May;34(5):917-22. doi: 10.1007/s00134-008-1022-y. Epub 2008 Feb 8. Intensive Care Med. 2008. PMID: 18259725
Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock.
Dhainaut JF, Antonelli M, Wright P, Desachy A, Reignier J, Lavoue S, Charpentier J, Belger M, Cobas-Meyer M, Maier C, Mignini MA, Janes J. Dhainaut JF, et al. Among authors: charpentier j. Intensive Care Med. 2009 Jul;35(7):1187-95. doi: 10.1007/s00134-009-1436-1. Epub 2009 Mar 5. Intensive Care Med. 2009. PMID: 19263034 Clinical Trial.
The era of genomics: impact on sepsis clinical trial design.
Cariou A, Chiche JD, Charpentier J, Dhainaut JF, Mira JP. Cariou A, et al. Among authors: charpentier j. Crit Care Med. 2002 May;30(5 Suppl):S341-8. doi: 10.1097/00003246-200205001-00026. Crit Care Med. 2002. PMID: 12004257 Review.
[Activated protein C and septic shock].
Dhainaut JF, Marin N, Charpentier J. Dhainaut JF, et al. Among authors: charpentier j. Rev Prat. 2003 Jan 1;53(1):5-6. Rev Prat. 2003. PMID: 12673917 French. No abstract available.
Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial.
Dhainaut JF, Laterre PF, Janes JM, Bernard GR, Artigas A, Bakker J, Riess H, Basson BR, Charpentier J, Utterback BG, Vincent JL; Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Dhainaut JF, et al. Among authors: charpentier j. Intensive Care Med. 2003 Jun;29(6):894-903. doi: 10.1007/s00134-003-1731-1. Epub 2003 Apr 24. Intensive Care Med. 2003. PMID: 12712239 Clinical Trial.
268 results